Endotoxins in commercial vaccines
نویسندگان
چکیده
منابع مشابه
Evaluation of Quality of Two Commercial Oil-Emulsion Newcastle Disease Vaccines In-vivo and In-vitro
Background and Aims: Newcastle disease (ND) is a highly contagious disease in poultry with economic losses in the world. Vaccination is one of the most important ways for prevention and control of NDV, but there are reports of ND outbreaks in vaccinated chickens. Poor quality of the vaccines is one of the reasons of vaccine failure. In this study the quality of two commercial oil-emulsion Newca...
متن کاملChapter 11: HPV vaccines: commercial research & development.
We are now in the fortunate position of having two highly promising human papillomavirus (HPV) vaccines in the pipeline. Amidst the excitement of anticipating what these vaccines may be able to offer, it is worth pausing to look back at how the vaccine development story unfolded from an industrial perspective, since without the massive commitment shown by manufacturers over the last decade, wit...
متن کاملLipopolysaccharide endotoxins.
Bacterial lipopolysaccharides (LPS) typically consist of a hydrophobic domain known as lipid A (or endotoxin), a nonrepeating "core" oligosaccharide, and a distal polysaccharide (or O-antigen). Recent genomic data have facilitated study of LPS assembly in diverse Gram-negative bacteria, many of which are human or plant pathogens, and have established the importance of lateral gene transfer in g...
متن کاملBacterial endotoxins.
Endotoxins possess an intrinsic fascination that is nothing less than fabulous. They seem to have been endowed by nature with virtues and vices in the exact and glamorous proportions needed to render them irresistible to any investigator who comes to know them.
متن کاملProtection conferred by commercial infectious bronchitis (IB) vaccines against
The level o protection conferred by commercial vaccines against the new variant Nebraska 95 isolate was evaluated. Complete protection was observed when the IBV Arkansas vaccine was given and when the Massachusetts-Connecticut vaccine was given at 1 and at 1 and 10 days of age. However, partial protection was observed when the Massachusetts-Connecticut vaccine was given only at 10 days of age. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Applied and Environmental Microbiology
سال: 1978
ISSN: 0099-2240,1098-5336
DOI: 10.1128/aem.36.3.445-449.1978